Alkermes
oral atypical markets represent large opportunities oral schizophrenia oral bipolar i disorder branded market size annual commercial payer market share reported sales audit factored by indication using reported indication mix sob reported sales are higher than manufacturer reported net sales because does not incorporate all gross to net expenses reported audit factored by indication using reported indication mix sob sob data reported audit converted into mot and factored by indication using reported indication mix sob sob data for the oral atypical market specific to indications data includes schizophrenia and disorder data includes and other indications switches includes add on sob data all indications due to data limitations schizophrenia data includes disorder for which will not be indicated due to data limitations data includes other indications for which will not be indicated treatment switches occur each month growth year over year size share year over year | Alkermes
Company
Deck Type
Deck date
March 2021
Slide
21 of 144
Related slides by other companies
Results
August 2023
Results
November 2023
Results
February 2022
Results
February 2021
Other recent decks by Alkermes
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io